Form 4 for BBNX Beta Bionics, Inc.
Accepted 2026-09-15 16:15:22 ET · period of report 2026-09-14 · accession 0002048497-26-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-15 16:15 | 2026-09-14 | BBNX | Hopman Mark | Chief Commercial Off | S - Sale | $15.52 | -775 | 86.4K | -0.9% | -$12.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-14 | S | D | 775 | $15.52 | 86,382 | D | — | — | (F1) Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026. |